1,4-Dihydropyridinebutyrolactone-derived ring-opened ester and amide analogs targeting BET bromodomains

Arch Pharm (Weinheim). 2022 Nov;355(11):e2200288. doi: 10.1002/ardp.202200288. Epub 2022 Aug 8.

Abstract

Based on a previously reported 1,4-dihydropyridinebutyrolactone virtual screening hit, nine lactone ring-opened ester and seven amide analogs were prepared. The analogs were designed to provide interactions with residues at the entrance of the ZA loop of the testis-specific bromodomain (ZA) channel to enhance the affinity and selectivity for the bromodomain and extra-terminal (BET) subfamily of bromodomains. Compound testing by AlphaScreen showed that neither the affinity nor the selectivity of the ester and lactam analogs was improved for BRD4-1 and the first bromodomain of the testis-specific bromodomain (BRDT-1). The esters retained affinity comparable to the parent compound, whereas the affinity for the amide analogs was reduced 10-fold. A representative benzyl ester analog was found to retain high selectivity for BET bromodomains as shown by a BROMOscan. X-ray analysis of the allyl ester analog in complex with BRD4-1 and BRDT-1 revealed that the ester side chain is located next to the ZA loop and solvent exposed.

Keywords: AlphaScreen; BET selectivity; BROMOscan; X-ray; bromodomain and extra-terminal (BET) proteins.

MeSH terms

  • Amides / pharmacology
  • Cell Cycle Proteins
  • Esters / pharmacology
  • Humans
  • Lactones / chemistry
  • Male
  • Nuclear Proteins* / chemistry
  • Nuclear Proteins* / metabolism
  • Structure-Activity Relationship
  • Transcription Factors*

Substances

  • Amides
  • Cell Cycle Proteins
  • Esters
  • Nuclear Proteins
  • Transcription Factors
  • Lactones